Intrinsiqs

Is ADMA Biologics, Inc. overvalued?

ADMA Biologics, Inc. (ADMA) — key valuation metrics and fundamentals.

No verdict
Price
$13.68
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$3.03B
Dividend yield
0.0%
Return on equity
42.6%
Sector
Healthcare

See the full interactive analysis →

Fair value compares ADMA's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.